Mats Bengtsson
Biträdande klinikchef vid Institutionen för immunologi, genetik och patologi; Kliniska verksamheter; Klinisk immunologi och transfusionsmedicin
- E-post:
- mats.bengtsson@igp.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 61, 1tr
751 85 Uppsala - Postadress:
- Akademiska sjukhuset
751 85 Uppsala
- Akademiska meriter:
- DMSc
Publikationer
Senaste publikationer
Ingår i Transplant International, 2025
- DOI för Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
- Ladda ner fulltext (pdf) av Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
Ingår i Pain, s. 1404-1412, 2024
- DOI för Increased risk of persistent neuropathic pain after traumatic nerve injury and surgery for carriers of a human leukocyte antigen haplotype
- Ladda ner fulltext (pdf) av Increased risk of persistent neuropathic pain after traumatic nerve injury and surgery for carriers of a human leukocyte antigen haplotype
Ingår i Haematologica, s. 645-652, 2023
- DOI för Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
- Ladda ner fulltext (pdf) av Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
Ingår i Transplantation direct, 2023
- DOI för Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program
- Ladda ner fulltext (pdf) av Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program
Ingår i PLOS ONE, 2022
- DOI för Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
- Ladda ner fulltext (pdf) av Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
Alla publikationer
Artiklar i tidskrift
Ingår i Transplant International, 2025
- DOI för Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
- Ladda ner fulltext (pdf) av Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
Ingår i Pain, s. 1404-1412, 2024
- DOI för Increased risk of persistent neuropathic pain after traumatic nerve injury and surgery for carriers of a human leukocyte antigen haplotype
- Ladda ner fulltext (pdf) av Increased risk of persistent neuropathic pain after traumatic nerve injury and surgery for carriers of a human leukocyte antigen haplotype
Ingår i Haematologica, s. 645-652, 2023
- DOI för Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
- Ladda ner fulltext (pdf) av Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
Ingår i Transplantation direct, 2023
- DOI för Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program
- Ladda ner fulltext (pdf) av Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program
Ingår i PLOS ONE, 2022
- DOI för Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
- Ladda ner fulltext (pdf) av Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
Ingår i American Journal of Transplantation, s. 2869-2879, 2022
- DOI för Scandiatransplant acceptable mismatch program: 10 years with an effective strategy for transplanting highly sensitized patients
- Ladda ner fulltext (pdf) av Scandiatransplant acceptable mismatch program: 10 years with an effective strategy for transplanting highly sensitized patients
HLA-DQ heterodimers in hematopoietic cell transplantation
Ingår i Blood, s. 3009-3017, 2022
Ingår i Frontiers in Immunology, 2021
- DOI för Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations
- Ladda ner fulltext (pdf) av Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations
Ingår i Transplantation, s. 1808-1817, 2021
- DOI för Imlifidase desensitization in crossmatch-positive, highly-sensitized kidney transplant recipients: Results of an international phase 2 trial (Highdes)
- Ladda ner fulltext (pdf) av Imlifidase desensitization in crossmatch-positive, highly-sensitized kidney transplant recipients: Results of an international phase 2 trial (Highdes)
Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0
Ingår i HLA, s. 516-531, 2020
- DOI för Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0
- Ladda ner fulltext (pdf) av Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation
Ingår i Journal of Clinical Oncology, s. 2712-2718, 2020
HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation
Ingår i Blood, s. 362-369, 2020
Safety of Use of Tantalum in Total Hip Arthroplasty
Ingår i Journal of Bone and Joint Surgery. American volume, s. 368-374, 2020
Ingår i The Lancet Haematology, 2020
Identification of the novel HLA-B*08:181 allele in a volunteer donor for hematopoietic stem cells
Ingår i HLA, s. 485-486, 2019
Första svenska trepartsbytet av njurar kunde göras enligt plan
Ingår i Läkartidningen, 2019
Ingår i Human Immunology, s. 228-236, 2019
A new allele found in a volunteer hematopoietic stem cell donor: HLA-B*15:465
Ingår i HLA, s. 223-224, 2019
Ingår i American Journal of Transplantation, s. 2752-2762, 2018
- DOI för Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.
- Ladda ner fulltext (pdf) av Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.
Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.
Ingår i Clinical Pharmacology and Therapeutics, s. 843-853, 2018
- DOI för Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.
- Ladda ner fulltext (pdf) av Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.
Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation
Ingår i American Journal of Transplantation, s. 472-472, 2017
Ingår i HLA, s. 17-24, 2017
Report Of A False Negative Amplification Shown To Be A New Null Allele Variant
Ingår i HLA, s. 469-469, 2017
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
Ingår i New England Journal of Medicine, s. 442-453, 2017
Ingår i Tissue Antigens, s. 226-227, 2016
Ingår i HLA, s. 226-227, 2016
Ingår i Biology of blood and marrow transplantation, s. 2052-2060, 2015
Ingår i Transplant International, s. 73-73, 2015
HLA Typing By SMRT Sequencing: Advantages Of Full Length HLA Genotyping In Clinical Routine
Ingår i Tissue Antigens, s. 113-113, 2014
Ingår i American Journal of Transplantation, s. 2838-2845, 2014
Ingår i Transplantation, s. 666-666, 2014
Ingår i Clinical Orthopaedics and Related Research, s. 953-961, 2014
Ingår i Tissue Antigens, s. 53-+, 2014
HLA-B*27:05:25 - a further HLA-B*27:05 allele with a synonymous nucleotide substitution
Ingår i Tissue Antigens, s. 131-132, 2014
Ingår i PLOS ONE, 2013
- DOI för Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
- Ladda ner fulltext (pdf) av Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
Screening of mortality in transplant patients using an assay for immune function
Ingår i Transplant Immunology, s. 246-250, 2011
Early Developing Celiac Disease in Children With Cerebral Palsy
Ingår i Journal of Pediatric Gastroenterology and Nutrition - JPGN, s. 674-678, 2011
Ingår i Journal of immunotherapy (1997), s. 633-43, 2008
Ingår i Leukemia Research, s. 931-938, 2007
Ingår i The Prostate, s. 389-395, 2007
- DOI för Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy
- Ladda ner fulltext (pdf) av Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy
Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.
Ingår i Diabetes Care, s. 2191-7, 2004